Drug Trial Radar · NCT00153816
Vitamin D/Calcium Polyp Prevention Study
Last checked: Nov 20, 2026Latest source record: Mar 15, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,813
Actual
Start
Jul 2004
Primary completion
Oct 2013
Study completion Jun 2016
Sponsor
- Lead sponsor
- Dartmouth-Hitchcock Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Sep 12, 2005
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 45 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Extensive experimental and observational data suggest that intake of calcium and of vitamin D exert protective effects on colorectal neoplasia. Building on their previous work, the investigators will investigate the chemopreventive effect of vitamin D in the large bowel, to study whether calcium with vitamin D is more effective than calcium alone, and to confirm their positive finding regarding calcium. The goal of this study is the development of chemopreventive combinations that will reduce risk of colorectal neoplasia sufficiently to permit the lengthening of surveillance intervals in most patients and to clarify important issues regarding the mechanisms of colorectal carcinogenesis and chemoprevention.
Conditions
- Colorectal Cancer
- Polyps
- Adenomas
Interventions
Calcium CarbonateDrug
3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet
Vitamin D3Drug
1000 IU/daily; two tablets per day; 500 IU per tablet
placeboDrug
placebo; two tablets per day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Colorectal AdenomasTime frame: 1 to 10 years
Locations
11 sites in 2 countries. Site status is shown where the registry gives one.
University of Southern California
Los Angeles, California
University of Colorado
Denver, Colorado
Emory University
Atlanta, Georgia
University of Iowa
Iowa City, Iowa
University of Minnesota
Minneapolis, Minnesota
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire
University of North Carolina
Chapel Hill, North Carolina
Cleveland Clinic Foundation
Cleveland, Ohio
University of South Carolina
Columbia, South Carolina
University of Texas
Houston, Texas
University of Puerto Rico
San Juan, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.